A Pilot Phase II Study to Determine the Safety and Efficacy of the Combination of ONTAK With CHOP in Peripheral T-Cell Lymphoma.
Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Safety of the combination of ONTAK + CHOP is assessed every 3 weeks for 18 weeks using measures such as ECG, physical exam, weight and performance status, vital signs, and blood chemistry/hematology (every 6 weeks).
Every 3 weeks or as needed.
Yes
Francine Foss, M.D.
Study Chair
Yale University
United States: Institutional Review Board
#35
NCT00211185
March 2004
Name | Location |
---|---|
Fox Chase Cancer Center | Philadelphia, Pennsylvania 19111 |
Rush University Medical Center | Chicago, Illinois 60612-3824 |
Hackensack University Medical Center | Hackensack, New Jersey 07601 |
Virginia Oncology Associates | Newport News, Virginia 23606 |
Rocky Mountain Cancer Center | Denver, Colorado 80218 |
Ocala Oncology Center | Ocala, Florida 34474 |
Cancer Centers of the Carolinas | Greenville, South Carolina 29605 |
Missouri Cancer Associates | Columbia, Missouri 65201 |
Stanford Cancer Center | Stanford, California 94305-5824 |
New Mexico Cancer Care Associates | Santa Fe, New Mexico 87505-7670 |
Tyler Cancer Center | Tyler, Texas 75702 |
Cancer Care Northwest | Spokane, Washington 99202 |
Northwest Cancer Specialists | Vancouver, Washington 98664 |
New York Oncology Hematology, P.C. | Albany, New York 12208 |
New England Medical Center | Boston, Massachusetts |
Cancer Centers of Florida, P.A. | Orlando, Florida |
Texas Oncology | Dallas, Texas |
Minnesota Oncology Hematology, P.A. | Minneapolis, Minnesota 55407 |
Texas Cancer Center at Medical City | Dallas, Texas 75230 |
Allison Cancer Center | Midland, Texas 79701 |
West Texas Cancer Center | Odessa, Texas 79761 |
Yale University School Of Medicine | New Haven, Connecticut 06520 |
Hematology Oncology Associates | Phoenix, Arizona 85012 |
Greater Dayton Cancer Center | Kettering, Ohio 45409 |
Birmingham Hematology and Oncology | Birmingham, Alabama 35235 |
Texas Cancer Center | Abilene, Texas 79606 |
The Texas Cancer Center | Dallas, Texas 75237 |
El Paso Cancer Treatment Center | El Paso, Texas 79915 |
Longview Cancer Center | Longview, Texas 75601 |
Kansas City Cancer Centers | Kansas City, Missouri 64111 |
Raleigh Hematology Oncology Associates | Cary, North Carolina 27511 |
Kansas City Cancer Centers | Lenexa, Kansas |
Waco Cancer Care and Research Center | Waco, Texas 76712 |
Robert H. Lurie Comprehensive Cancer Center | Chicago, Illinois 60611 |
Puget Sound Cancer Center | Edmonds, Washington 98026 |
Hematology Oncology Associates of IL | Chicago, Illinois 60611 |
Cancer Care & Hematology Specialists of Chicagoland | Niles, Illinois 60714 |
Siouxland Hematology Oncology | Sioux City, Iowa 51101 |
Dana Farber/ Harvard Cancer Center | Boston, Massachusetts 02115 |
St. Joseph Oncology Inc. | St. Joseph, Missouri 64507 |
Arch Medical Services | St. Louis, Missouri 63141 |
Hematology Oncology Associates of NNJ | Morristown, New Jersey 07960 |
Barrett Cancer Center-University of Cincinnati | Cincinnati, Ohio 45206 |
Marnie McFaddin Ward Cancer Center | Beaumont, Texas 77702-1449 |
Texas Oncology,P.A. | Bedford, Texas 76022 |
HOAST Medical Dr. | San Antonio, Texas 78229 |
Oncology and Hematology Associates of SW VA Inc. | Salem, Virginia 24153 |
Yakima Valley Memorial Hospital/North Star Lodge | Yakima, Washington 98902 |